Klinik Loewenstein gGmbH
- Address
- Geisshölzle 62, 74245 Loewenstein, Germany
Klinik Loewenstein gGmbH - Thoracic Oncology Research
Klinik Loewenstein gGmbH is a specialized medical research center dedicated to advancing treatment approaches for thoracic malignancies. The institution demonstrates particular expertise in evaluating innovative therapeutic strategies for patients with surgically resectable lung cancers, focusing on optimizing perioperative care through cutting-edge immunotherapy protocols.
- Non-small cell lung cancer (NSCLC) in resectable stages
- Perioperative immunotherapy combining chemotherapy with checkpoint inhibitors
- Phase 3 clinical trials evaluating event-free survival outcomes
The center's research portfolio emphasizes resectable Stage II-IIIB non-small cell lung cancer, with investigations into neoadjuvant and adjuvant nivolumab therapy. Their participation in sophisticated randomized, double-blind studies reflects a commitment to generating robust evidence for perioperative treatment optimization in thoracic oncology, ultimately aiming to improve long-term outcomes for patients with operable lung cancer.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinik Loewenstein gGmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind Study of Neoadjuvant Chemotherapy plus Nivolumab versus Neoadjuvant Chemotherapy plus Placebo, followed by Surgical Resection and Adjuvant Treatment with Nivolumab or Placebo for Participants with Resectable Stage II-IIIB Non-small Cell Lung Cancer (CheckMate 77T, CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 77T) | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Recruiting | Sep 2019 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 1 | Unknown | 2019-09-22 | 2019-09-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.